Protective T cell responses to Chlamydial Infection
Protective T cell responses to Chlamydial Infection
批准号:
8137731
负责人:
Thomas L. Cherpes
金额:
$44.19万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAntigensBacteriaBacterial Sexually Transmitted DiseasesBlood CellsCD4 Positive T LymphocytesCD8B1 geneCellsCervicitisChlamydiaChlamydia InfectionsChlamydia trachomatisClinical DataClinical ResearchCollectionContainmentDataDiseaseEctopic PregnancyEndometrialEndometriumEnrollmentExperimental ModelsGenital systemHeat shock proteinsHigh Risk WomanHumanIL2RA geneImmuneImmune responseImmunityImmunologicsInfectionInfertilityInterferon Type IIInterleukin-10Interleukin-17Interleukin-4InvestigationKenyaLymphocyteMammalian OviductsMeasuresMediatingMembrane ProteinsOrganismPelvic Inflammatory DiseasePeripheralPeripheral Blood Mononuclear CellPhenotypeProductionProspective StudiesProstitutionProteinsRecruitment ActivitySecondary toStructureT cell responseT-LymphocyteTissuesUnited StatesVaccinesWomanadverse outcomebasecell mediated immune responsechronic pelvic paincohortdesignhigh riskimmunogenicmajor outer membrane proteinmicroorganismnovelresponsevaccine candidatevaccine development
中文摘要
盆腔炎性疾病(PID)定义为子宫内膜、输卵管及其邻近组织的感染,
这是由微生物从下生殖道Ascension到上生殖道引起的。
最令人信服的与PID相关的微生物是沙眼衣原体,我们的建议将
为发现抗原特异性细胞介导的免疫反应提供了令人兴奋的机会,
最强相关的保护对C。沙眼感染以及抗原的阐明
特异性免疫应答与C.下生殖道沙眼感染的
将从急性PID队列(项目1)中招募200名入组本纵向研究的女性
以及来自宫颈内感染C.沙眼(项目4)。
完成我们的调查将允许:
1.更好地理解与CD4 T细胞抗原特异性反应密切相关的CD4 T细胞抗原特异性反应,
保护C。入组时的沙眼感染。
2.更好地阐明了CD4 T细胞抗原特异性应答,这些应答与
保护免受C事件的影响。沙眼感染
3.鉴定新的衣原体特异性T细胞应答,其与免疫应答最密切相关。
降低了C Ascension的可能性。沙眼从下到上生殖道。
英文摘要
Pelvic inflammatory disease (PID) is defined as an infection of the endometrium, fallopian tubes, and adjacent
structures that is caused by the ascension of microorganisms from the lower to upper genital tract The
microorganism most convincingly associated with PID is Chlamydia trachomatis, and our proposal would
provide the exciting opportinity for a discovery of the antigen-specific cell mediated immune resposes that are
most strongly associated with protection against C. trachomatis infection as well as the elucidation of the antigen
specifc immune responses correlated with containment of C. trachomatis infection to the lower genital tract. The
200 women enrolled into this longitudinal investigation will be recruited from an acute PID cohort (Project 1)
and from a cohort of women who are at high risk for endocervical infection with C. trachomatis (Project 4).
Completion of our investigation will allow:
1. Better understanding of the CD4 T cell antigen-specific responses that are most strongly associated with
protection from C. trachomatis infection at enrollment.
2. Better elucidation of the CD4 T cell antigen-specific responses that are most strongly correlated with
protection from incident C. trachomatis infection.
3. Identification of novel chlamydia-specific T cell responses that are most strongly associated with the
decreased likelihood of ascension of C. trachomatis from the lower to upper genital tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function
-
批准号:10901049
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2023
-
负责人:Thomas L. Cherpes
-
依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
-
批准号:10024512
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2018
-
负责人:Thomas L. Cherpes
-
依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
-
批准号:10412065
-
项目类别:
-
资助金额:$75.07万
-
财政年份:2018
-
负责人:Thomas L. Cherpes
-
依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
-
批准号:10172944
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2018
-
负责人:Thomas L. Cherpes
-
依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
-
批准号:10458240
-
项目类别:
-
资助金额:$70.45万
-
财政年份:2018
-
负责人:Thomas L. Cherpes
-
依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
-
批准号:9769814
-
项目类别:
-
资助金额:$71.4万
-
财政年份:2018
-
负责人:Thomas L. Cherpes
-
依托单位:
Modulation of hormonal and systemic immunity by hormonal contraceptive use
-
批准号:8659112
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2013
-
负责人:Thomas L. Cherpes
-
依托单位:
Modulation of hormonal and systemic immunity by hormonal contraceptive use
-
批准号:8606863
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2013
-
负责人:Thomas L. Cherpes
-
依托单位:
Modulation of Hormonal and Systemic Immunity by Hormonal Contraceptive Use
-
批准号:8462133
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2012
-
负责人:Thomas L. Cherpes
-
依托单位:
Modulation of Hormonal and Systemic Immunity by Hormonal Contraceptive Use
-
批准号:8318311
-
项目类别:
-
资助金额:$49.74万
-
财政年份:2012
-
负责人:Thomas L. Cherpes
-
依托单位:
Tregs:sculpting a balance between protection and pathology during viral infection
-
批准号:8090575
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2010
-
负责人:Thomas L. Cherpes
-
依托单位:
Protective T cell responses to Chlamydial Infection
-
批准号:7762461
-
项目类别:
-
资助金额:$35.36万
-
财政年份:2009
-
负责人:Thomas L. Cherpes
-
依托单位:
HSV-2 shedding: role of hormonal contraception and BV
-
批准号:7425431
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:Thomas L. Cherpes
-
依托单位:
HSV-2 shedding: role of hormonal contraception and BV
-
批准号:6908373
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2005
-
负责人:Thomas L. Cherpes
-
依托单位:
HSV-2 shedding: role of hormonal contraception and BV
-
批准号:7060899
-
项目类别:
-
资助金额:$12.64万
-
财政年份:2005
-
负责人:Thomas L. Cherpes
-
依托单位:
HSV-2 shedding: role of hormonal contraception and BV
-
批准号:7617270
-
项目类别:
-
资助金额:$12.66万
-
财政年份:2005
-
负责人:Thomas L. Cherpes
-
依托单位:
Protective T cell responses to Chlamydial Infection
-
批准号:8379413
-
项目类别:
-
资助金额:$45.11万
-
财政年份:--
-
负责人:Thomas L. Cherpes
-
依托单位:
Protective T cell responses to Chlamydial Infection
-
批准号:8529453
-
项目类别:
-
资助金额:$42.55万
-
财政年份:--
-
负责人:Thomas L. Cherpes
-
依托单位:
Protective T cell responses to Chlamydial Infection
-
批准号:8314064
-
项目类别:
-
资助金额:$48.47万
-
财政年份:--
-
负责人:Thomas L. Cherpes
-
依托单位:
Protective T cell responses to Chlamydial Infection
-
批准号:8810766
-
项目类别:
-
资助金额:$27.86万
-
财政年份:--
-
负责人:Thomas L. Cherpes
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: